查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836774

氧气疗法设备市场（按产品类型、技术、最终用户和应用）—全球预测 2025-2032

Oxygen Therapy Devices Market by Product Type, Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，氧气疗法设备市场规模将成长至 46.8 亿美元，复合年增长率为 6.99%。

主要市场统计数据
基准年2024年 27.3亿美元
预计2025年 29.1亿美元
预测年份：2032年 46.8亿美元
复合年增长率（%） 6.99%

氧气疗法设备的精彩介绍：揭示临床驱动因素，包括以患者为中心的采用趋势、技术创新和护理服务方式的转变

氧气疗法设备如今广泛应用于各种临床环境，从急诊医院到居家管理项目，并在现代呼吸护理中发挥核心作用。设备便携性、能源效率和降噪方面的进步正在重塑患者的期望，并推动着向门诊病人和居家医疗模式的转变。随着临床指引日益强调早期疗育、持续照护和以病人为中心的治疗方案，氧气疗法的设计和实施也在不断发展，以满足临床有效性和生活方式的考量。

同时，医疗保健提供者和设备製造商正在应对不断变化的报销模式，并不断加强与数位医疗的整合。远端监控、远端医疗支援的依从性追踪以及数据驱动的治疗优化正在扩展氧气系统的价值提案，使其超越简单的气体输送。最终的结果是形成一个动态的环境，临床需求、法律规范和技术能力相互交织，为采用和差异化开闢了新的途径。本引言将组装影响急性和非急性照护中采购决策、临床通讯协定和供应链策略的关键驱动因素，为后续分析提供框架。

临床实务技术和供应链策略的转型将重塑氧气疗法设备的设计、製造和部署方式

氧气疗法设备领域正在经历一场变革，涵盖临床实践、技术和供应链架构。临床上，护理的去中心化趋势明显，曾经仅限于住院治疗的治疗，如今已在门诊手术中心和家中进行。这种转变是由携带式氧气浓缩机的进步、低耗电量以及整合监测功能所推动的，这些技术都有助于提高患者的活动能力和依从性。因此，製造商优先考虑使用者体验、电池效率和整合数位功能，以满足患者的实际需求。

同时，技术发展轨迹也为氧气的生产和输送提供了更多选择。变压式吸附和薄膜技术已经成熟，可以支援现场製氧和紧凑型设计，从而减少某些护理情况下对气瓶发行的物流依赖。低温蒸馏仍然是大规模液态氧输送的首选方法，因为规模经济可以证明集中生产的合理性。因此，不同的技术基于规模、移动性和输送成本的考量，正在开拓不同的市场。

供应链创新也是一个决定性的转变。为了因应贸易政策的不确定性以及维持临床连续性的需要，区域製造和近岸外包策略正日益受到青睐。製造商正在实现压缩机、筛床和电子控制模组等关键零件供应商的多元化，以降低单一来源风险。最后，监管和报销制度的变化正在推动临床证据生成与产品开发之间更加紧密的衔接，鼓励製造商投资于能够证明疗效并支持在医疗机构中推广的临床和疗效研究。

评估2025年美国关税对製造业采购定价权和竞争力的累积影响

2025年关税对氧气疗法设备生态系统产生了累积影响，改变了采购、生产和分销的经济效益。进口零件和成品设备关税上调促使製造商重新评估长期以来的筹资策略，并加速了对本地生产和供应商多元化的兴趣。随着关税上调导致某些进口产品的到岸成本上升，现有企业和新参与企业都在权衡本地製造产能的资本投资与供应链重组带来的短期成本压力之间的利弊。

这种环境也影响着策略定价和合约行为。付款人和机构投资者要求更清楚地了解整体拥有成本，包括服务、维护和物流，这促使供应商完善其基于价值的提案和捆绑式报价。同时，一些製造商正在加速产品重新设计，以减少对受关税影响组件的依赖，优先考虑模组化和使用更容易采购的子组件。因此，市场竞争力如今取决于能否展现营运韧性、合约弹性和供应安全性。

此外，随着企业试图迁移或扩大生产规模，监管时间表和跨境认证流程已成为重大摩擦点。相关人员越来越多地将贸易政策情境规划与监管机构的沟通结合起来，以避免设备供应中断。总而言之，关税环境不仅影响短期成本结构，也影响生产地点、供应商关係和商业性提案的长期策略调整。

关键细分洞察揭示了产品类型技术、最终用户和临床应用如何塑造差异化的采用路径和服务要求

细分显示，不同产品采用路径存在细微差异，这些路径因产品设计、实行技术、医疗环境和临床应用而异。从产品类型来看，液氧系统仍然与集中供应模式相关，在这种模式下，高容量需求和仓储物流是其合理使用的理由；氧气浓缩机主要应用于需要持续门诊或居家使用的场景；而氧气瓶则继续用于应对偶发性和紧急需求。在氧气浓缩机类别中，携带式和固定式设备的区别决定了购买标准：携带式设备优先考虑移动性和生活质量，而固定式设备则适用于在固定护理场所进行持续可靠的治疗。

技术选择与产品选择相互交织，并决定了营运的权衡。低温蒸馏支持大型液体供应链，通常与集中式基础设施相关；而变压式吸附则凭藉其效率和扩充性的平衡，在现场发电和紧凑型浓缩器设计中占据主导地位。这些技术差异会影响维护方法、生命週期考量和总成本动态，进而指南不同买家的采购偏好。

最终用户有明确的要求，这些要求会影响设备规格和服务模式。门诊手术中心要求快速的设备设置、标准化的维护通讯协定和紧凑的解决方案。家庭医疗保健提供者优先考虑易于设定、低噪音和远端监控功能，以支援患者依从性。医院和诊所通常要求设备具有强大的临床认证、整合到治疗通讯协定中并具有可预测的服务等级协定。气喘和其他慢性肺部疾病通常强调长期依从性和舒适性，慢性阻塞性肺病需要可靠的氧浓度滴定和持久运行，阻塞型睡眠呼吸中止症明确考虑夜间分娩，肺炎和呼吸窘迫症候群需要快速反应并与急性护理工作流程相容。整合产品、技术、最终用户和应用视角使相关人员能够根据差异化的临床和营运需求调整研发重点和打入市场策略。

影响美洲、欧洲、中东和非洲以及亚太地区氧气疗法设备的区域力量及其对製造和市场进入的实际影响

区域动态显着影响氧气疗法设备的製造、监管和商业化方式。在美洲，买家通常看重快速取得、整合服务网络和与报销挂钩的采购方式，青睐能够提供强大售后服务和临床证据的供应商。尤其是美国市场对法规合规性和数据整合有着很高的标准，鼓励製造商将产品开发与当地认证和临床试验预期相结合。相较之下，拉丁美洲市场则优先考虑经济高效的解决方案和灵活的维护机制，这可能为建立灵活的服务模式和区域伙伴关係关係创造机会。

在欧洲、中东和非洲，多样化的法规和不断变化的医疗基础设施需要灵活的通路策略。同时，中东和非洲国家将快速现代化的医疗体系与资源受限的环境结合。在许多此类环境中，能够提供在电力和物流受限的环境中运行的可扩展解决方案是一项竞争优势。同时，亚太地区呈现多样化的格局。在一些国家，成熟的医疗体系需要功能丰富的设备和数位化集成，而新兴市场则优先考虑价格承受能力和本地服务能力。亚太地区的製造地也对全球供应发挥战略作用，影响企业如何跨时区和贸易走廊分配生产和管理分销。

整体而言，区域差异将影响产品组合、定价策略和合作模式的决策。根据当地临床方案和基础设施的实际情况定制产品的製造商将能够更有效地进入市场并获得持续的采用。

重新定义供应链创新投资伙伴关係和服务交付模式的公司层级策略发展和竞争行为

公司层面的竞争态势以产品创新、策略伙伴关係和服务扩展相结合为特征。领先的公司正在投资浓缩器效率、电池寿命和使用者介面的渐进式改进，同时探索远端监控和远端患者管理等领域的协同机会。这些努力通常与医疗保健提供者和技术供应商建立策略联盟相辅相成，从而能够快速整合到临床工作流程中并简化证据产生。

新参与企业和专业製造商瞄准具有明确价值提案的利基市场，例如超轻型可携式聚光器和专为分散式设施量身定制的模组化现场发电系统。现有企业则透过增强服务能力、扩展维护网路以及选择性收购来填补技术和地理空白，以应对这一市场。供应链弹性已成为一个竞争关键，促使企业投资于多源采购、区域仓储和预测性维护计划，以减少停机时间并提高客户维繫。

对于寻求加快产品审批并使产品核可符合当地临床指南的公司来说，与监管机构的合作也成为一项关键挑战。拥有强大的临床数据集和清晰的上市后监测计划的公司，更有机会获得机构管道的支援。最后，商业性策略也越来越强调加值附加价值服务，例如疗效追踪、依从性分析和整合耗材管理。

为行业领导者提供可行的建议，以优化产品系列、增强供应弹性、利用数位健康并加速商业性执行

行业领导者可以采取一系列切实可行的优先事项，以在快速发展的氧气疗法市场中抓住机会并管理风险。首先，优先考虑模组化产品架构，以减少对受关税影响元件的依赖，并实现快速在地化生产。这种方法既有助于控製成本，又能灵活回应当地监管要求。其次，加快对携带式浓缩器功能和电池创新的投资，以顺应居家医疗和患者移动化趋势。

第三，我们将把数位医疗功能嵌入到我们的设备生态系统中，以实现远端监控、依从性支援和数据驱动的临床决策。整合远端医疗功能将增强产品差异化，并支持付款人围绕疗效和价值进行对话。第四，我们将透过多元化供应商、建立区域製造伙伴关係以及投资预测性维护框架来增强供应链的韧性，以最大限度地减少服务中断。第五，我们将积极与监管机构和付款人合作，使临床证据要求与报销途径一致，从而加快机构环境的采用。

最后，采用灵活的商业模式，将服务合约和基于绩效的要素与设备销售结合。透过转向以价值为导向的合约和全面的服务，製造商可以建立更牢固的客户关係，同时平滑收益波动。各组织可以协作实施这些建议，以维持整个医疗保健领域的成长选择，同时应对政策变革、技术变革和不断变化的临床期望。

调查方法和资料来源采用严格的混合方法，结合初步研究和技术检验，并跨多个资料来源进行三角测量以确保准确性。

本分析所依据的研究采用了严格的混合方法，以确保可靠性和实用效度。初步研究包括对临床医生、生物医学工程师、采购主管和设备製造商的结构化访谈，以获得关于设备性能、服务期望和采用障碍的第一手见解。二次研究整合了广泛的公开资讯来源，包括监管备案文件、临床指南、专利文献和技术白皮书，以检验技术和监管背景。对一手和二次研究的数据进行迭代三角检验，以协调不同的观点并提高定性研究观察的可靠性。

分析步骤包括对访谈记录进行主题编码、识别反覆出现的痛点和机会领域、交叉比较产品规格以确定功能差异，以及透过情境分析对贸易政策变化和供应链中断的战略应对措施进行压力测试。专家审查了研究结果初稿，以确保技术准确性并确保结论与当前临床实践相符。在适用的情况下，明确记录了调查方法的局限性和假设，以帮助解读并指南使用者根据自身工作情况调整研究见解。

总结性综合报告汇集了临床、技术、监管和商业性主题，为相关人员阐明了机会和策略要务

最终的综合报告汇集了临床、技术、监管和商业主题，阐明了对相关人员的策略重要性。临床驱动的分散化，加上携带式浓缩器技术的进步和支持性的数位生态系统，为家庭医疗保健和门诊环境的增长开闢了清晰的道路，同时在某些大批量生产情况下仍保留了集中式液态氧的作用。监管和政策变化（包括贸易相关措施）再形成製造和采购的优先事项，提升了区域产能和供应商多元化的重要性。

商业性成功取决于能否将产品创新与可证明的临床价值和可靠的服务交付相结合。能够将高效的设备平台与强大的售后服务网路和数据驱动服务相结合的公司将更有能力赢得持久的客户关係。总而言之，氧气疗法治疗设备产业正进入一个临床需求、技术成熟度和政策动态融合的阶段，推动策略差异化发展。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将支援物联网的远端监控功能整合到氧气疗法设备中，以支援远端医疗服务。
  • 开发一种结合连续流量和脉衝剂量的混合氧气浓缩机，为患者提供灵活性
  • 家庭氧气疗法报销政策的扩大正在推动慢性呼吸系统疾病患者越来越多地采用家庭氧气治疗
  • 小型轻量携带式氧气设备的进步延长了户外活动期间的电池寿命
  • 人工智慧驱动的氧气输送系统根据即时患者健康指标优化流速

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章氧气疗法设备市场（依产品类型）

  • 液态氧系统
  • 氧气浓缩机
    • 可携带式氧气设备
    • 固定式氧气浓缩机
  • 氧气罐

第九章氧气疗法设备市场（按技术）

  • 低温蒸馏
  • 膜分离
  • 变压式吸附

第 10 章氧气疗法设备市场（依最终用户）

  • 门诊手术中心
  • 家庭医疗保健
  • 医院和诊所

第 11 章氧气疗法设备市场（按应用）

  • 气喘和其他肺部疾病
  • 慢性阻塞性肺病（COPD）
  • 阻塞型睡眠呼吸中止症症（OSA）
  • 肺炎和呼吸窘迫综合征

第十二章氧气疗法设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章氧气疗法设备市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章氧气疗法设备市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Koninklijke Philips NV
    • ResMed Inc.
    • Chart Industries, Inc.
    • Inogen, Inc.
    • Drive DeVilbiss Healthcare, Inc.
    • Invacare Corporation
    • GE HealthCare Technologies Inc.
    • Parker-Hannifin Corporation
    • Nidek Medical Products, Inc.
    • O2 Concepts, Inc.
Product Code: MRR-036C5CF3B4F1

The Oxygen Therapy Devices Market is projected to grow by USD 4.68 billion at a CAGR of 6.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.73 billion
Estimated Year [2025] USD 2.91 billion
Forecast Year [2032] USD 4.68 billion
CAGR (%) 6.99%

A compelling introduction to oxygen therapy devices delineating clinical drivers patient-centric adoption trends technological innovations and care delivery shifts

Oxygen therapy devices now occupy a central role in contemporary respiratory care, serving a spectrum of clinical settings from acute hospitals to home-based management programs. Advances in device portability, power efficiency, and noise reduction have reshaped patient expectations and enabled a greater shift toward outpatient and home healthcare models. As clinical guidelines increasingly emphasize early intervention, continuity of care, and patient-centric regimens, the design and delivery of oxygen therapy are evolving to meet both clinical efficacy and lifestyle considerations.

At the same time, care providers and device manufacturers are responding to shifting reimbursement paradigms and the growing integration of digital health. Remote monitoring, telehealth-enabled adherence tracking, and data-driven therapy optimization are expanding the value proposition of oxygen systems beyond simple gas delivery. The net effect is a dynamic environment in which clinical demand, regulatory oversight, and technological capability intersect to create new pathways for adoption and differentiation. This introduction frames the subsequent analysis by highlighting the primary drivers that are shaping purchasing decisions, clinical protocols, and supply chain strategies across acute and non-acute care settings.

Transformative shifts in clinical practice technology and supply chain strategies that are reshaping how oxygen therapy devices are designed produced and deployed

The landscape for oxygen therapy devices is undergoing transformative shifts that span clinical practice, technology, and supply chain architecture. Clinically, there is an evident move toward decentralization of care: treatments once confined to inpatient settings are now delivered in ambulatory surgical centers and the home. This transition is propelled by advances in portable oxygen concentrators, lower power consumption, and the integration of monitoring capabilities, all of which support greater patient mobility and adherence. Consequently, manufacturers are prioritizing user experience, battery efficiency, and integrated digital features to align with real-world patient needs.

Concurrently, technological trajectories are multiplying options for oxygen production and delivery. Pressure swing adsorption and membrane technologies have matured to support on-site generation and compact designs, reducing logistical dependence on cylinder distribution in certain care contexts. Cryogenic distillation remains relevant for large-scale liquid oxygen supply where economies of scale justify centralized production. As a result, different technologies are carving distinct niches based on scale, mobility, and cost-to-serve considerations.

Supply chain innovation is another defining shift. Regional manufacturing and nearshoring strategies are gaining traction in response to trade policy volatility and the imperative to maintain clinical continuity. Manufacturers are diversifying supplier bases for critical components such as compressors, sieve beds, and electronic control modules to reduce single-source risks. Finally, regulatory and reimbursement changes are prompting closer alignment between clinical evidence generation and product development, encouraging manufacturers to invest in clinical studies and outcomes research that substantiate effectiveness and support uptake across varied care settings.

Evaluating the cumulative consequences of United States tariff measures in 2025 on manufacturing sourcing pricing dynamics and competitive repositioning across the sector

The imposition of tariff measures in 2025 has exerted a cumulative influence on the oxygen therapy devices ecosystem, altering the economics of sourcing, production, and distribution. Increased duties on imported components and finished devices have incentivized manufacturers to revisit long-established procurement strategies, accelerating interest in local production and supplier diversification. As tariffs raise landed costs for certain imports, incumbent players and new entrants have been evaluating the trade-offs between capital investment in regional manufacturing capacity and the short-term cost pressures associated with reconfigured supply chains.

This environment has also influenced strategic pricing and contracting behavior. Payers and institutional buyers are seeking greater clarity around total cost of ownership, including service, maintenance, and logistics, which has led suppliers to refine value-based propositions and bundled offerings. In parallel, some manufacturers have accelerated product redesigns to reduce reliance on tariff-exposed components, prioritizing modularity and the use of more readily sourced subcomponents. The net result is a market in which operational resilience, contractual flexibility, and the ability to demonstrate consistent supply have become central competitive differentiators.

Moreover, regulatory timelines and cross-border certification processes have surfaced as critical friction points when companies attempt to relocate or scale manufacturing. Stakeholders are increasingly combining trade-policy scenario planning with regulatory engagement to avoid disruptions to device availability. Taken together, the tariff environment has not only influenced near-term cost structures but also catalyzed longer-term strategic adjustments in production footprints, supplier relationships, and commercial propositions.

Key segmentation insights revealing how product types technologies end users and clinical applications shape differentiated adoption pathways and service requirements

Segmentation reveals nuanced pathways to adoption that vary according to product design, enabling technology, care setting, and clinical application. When viewed through the lens of product type, liquid oxygen systems remain relevant for centralized supply models where high-volume demand and storage logistics justify their use, oxygen concentrators dominate scenarios requiring sustained ambulatory or home use, and cylinders continue to serve episodic and emergency needs. Within the concentrator category, distinctions between portable units and stationary systems shape purchase criteria, with portable devices prioritized for mobility and quality-of-life considerations and stationary units chosen for continuous, reliable therapy in fixed care locations.

Technology choices intersect with product selection to inform operational trade-offs. Cryogenic distillation underpins large-scale liquid supply chains and is typically associated with centralized infrastructure. Membrane separation technologies provide lighter-weight options that can be favorable in portable and decentralized contexts, while pressure swing adsorption has become a mainstream choice for both on-site generation and compact concentrator designs due to its balance of efficiency and scalability. These technology differentials influence maintenance practices, lifecycle considerations, and total cost dynamics, and therefore guide procurement preferences across different buyers.

End users exhibit distinct requirements that impact device specification and service models. Ambulatory surgical centers demand rapid device readiness, standardized maintenance protocols, and compact footprint solutions. Home healthcare providers prioritize easy setup, low noise emissions, and remote monitoring capabilities to support patient adherence. Hospitals and clinics typically require devices with robust clinical certifications, integration into therapeutic protocols, and predictable service-level agreements. Finally, clinical application drives clinical efficacy expectations and device customization: asthma and other chronic lung conditions often emphasize long-term adherence and comfort, chronic obstructive pulmonary disease requires reliable oxygen titration and durable operation, obstructive sleep apnea presents distinct nocturnal delivery considerations, and pneumonia and respiratory distress syndromes necessitate rapid responsiveness and compatibility with acute care workflows. By integrating product, technology, end-user, and application lenses, stakeholders can align R&D priorities and go-to-market strategies with differentiated clinical and operational needs.

Regional forces shaping oxygen therapy devices across the Americas Europe Middle East and Africa and Asia-Pacific with practical implications for manufacturing and market access

Regional dynamics exert a material influence on how oxygen therapy devices are manufactured, regulated, and commercialized. In the Americas, buyers often emphasize rapid access, integrated service networks, and reimbursement-aligned purchasing, which favors suppliers that can demonstrate robust aftersales support and clinical evidence. The United States market in particular drives high standards for regulatory compliance and data integration, prompting manufacturers to align product development with local certification and clinical trial expectations. In contrast, Latin American markets may prioritize cost-effective solutions and flexible maintenance arrangements, creating opportunities for adaptable service models and regional partnerships.

Across Europe, the Middle East, and Africa, regulatory diversity and variable healthcare infrastructure require flexible channel strategies. Western European markets typically mandate stringent clinical validation and benefit from established hospital procurement frameworks, while countries across the Middle East and Africa present a mix of rapid modernizing healthcare systems and resource-constrained environments. In many of these settings, the ability to offer scalable solutions that can operate in constrained power and logistics conditions is a competitive advantage. Meanwhile, Asia-Pacific displays a broad spectrum of circumstances: mature healthcare systems in some countries demand feature-rich devices and digital integration, whereas emerging markets prioritize affordability and local service capability. Manufacturing footprints in Asia-Pacific also play a strategic role for global supply, shaping how companies allocate production and manage distribution across time zones and trade corridors.

Taken together, regional variation informs decisions on product configuration, pricing strategies, and partnership models. Manufacturers that align their offerings to regional clinical protocols and infrastructure realities can achieve more effective market entry and sustained adoption.

Strategic company level developments and competitive behaviors that are redefining supply chains innovation investments partnerships and service delivery models

Competitive dynamics at the company level are characterized by a mix of product innovation, strategic partnerships, and service expansion. Leading firms are investing in incremental improvements to concentrator efficiency, battery life, and user interfaces while simultaneously exploring adjacent opportunities in telemonitoring and remote patient management. These efforts are often complemented by strategic alliances with healthcare providers and technology vendors that enable faster integration into clinical workflows and streamline evidence generation.

New entrants and specialized manufacturers are targeting niche segments with distinct value propositions, such as ultra-lightweight portable concentrators or modular on-site generation systems tailored for decentralized facilities. Established companies are responding by reinforcing their service capabilities, expanding maintenance networks, and pursuing selective acquisitions to fill technological or geographic gaps. Supply chain resilience has become a competitive battleground, prompting investments in multi-source procurement, regional warehousing, and predictive maintenance programs to reduce downtime and improve customer retention.

Regulatory engagement is also prominent as companies seek to expedite product approvals and align labeling with regional clinical guidelines. Firms that combine robust clinical data packages with clear post-market surveillance plans are better positioned to gain traction in institutional channels. Finally, the commercial playbook increasingly emphasizes value-added services-such as outcome tracking, adherence analytics, and integrated consumables management-that create recurring revenue streams and strengthen customer relationships across acute and non-acute care settings.

Actionable recommendations for industry leaders to optimize product portfolios strengthen supply resilience leverage digital health and accelerate commercial execution

Industry leaders can pursue a set of actionable priorities to capture opportunity and manage risk in a rapidly evolving oxygen therapy market. First, prioritize modular product architectures that reduce dependence on tariff-exposed components and allow faster localization of production. This approach supports both cost containment and agility in responding to regional regulatory requirements. Second, accelerate investment in portable concentrator capabilities and battery innovations, which align directly with the trend toward home-based care and patient mobility.

Third, embed digital health features into device ecosystems to enable remote monitoring, adherence support, and data-driven clinical decision-making. Integrating telehealth capabilities enhances product differentiation and supports payer conversations about outcomes and value. Fourth, fortify supply chain resilience by diversifying suppliers, establishing regional manufacturing partnerships, and investing in predictive maintenance frameworks to minimize service interruptions. Fifth, engage proactively with regulatory authorities and payers to align clinical evidence requirements with reimbursement pathways, thereby reducing time-to-adoption in institutional settings.

Finally, adopt flexible commercial models that combine device sales with service contracts and outcome-based elements. By shifting toward value-oriented agreements and comprehensive service offerings, manufacturers can create stickier customer relationships while smoothing revenue volatility. Executed in concert, these recommendations will help organizations navigate policy shifts, technological change, and evolving clinical expectations while preserving growth options across care settings.

Research methodology outlining a rigorous mixed methods approach that combines primary interviews technical validation and multi source data triangulation to ensure accuracy

The research underpinning this analysis employed a rigorous mixed-methods approach designed to ensure reliability and practical relevance. Primary research included structured interviews with clinicians, biomedical engineers, procurement leaders, and device manufacturers to surface first-hand insights on device performance, service expectations, and adoption barriers. Secondary research incorporated a wide range of publicly available sources such as regulatory filings, clinical guidelines, patent literature, and technical white papers to validate technological and regulatory context. Data from both primary and secondary streams were subjected to iterative triangulation to reconcile divergent perspectives and enhance confidence in qualitative findings.

Analytical steps included thematic coding of interview transcripts to identify recurring pain points and opportunity areas, cross-comparison of product specifications to map functional differentiation, and scenario analysis to stress-test strategic responses to trade-policy changes and supply-chain disruptions. Subject-matter experts reviewed draft findings to ensure technical accuracy and to confirm that conclusions were consistent with current clinical practice. Where applicable, methodological limitations and assumptions were explicitly documented to inform interpretation and to guide users in adapting insights to their specific operational contexts.

Concluding synthesis integrating clinical technological regulatory and commercial themes to clarify opportunities and strategic imperatives for stakeholders

The concluding synthesis integrates clinical, technological, regulatory, and commercial threads into a coherent set of strategic implications for stakeholders. Clinically driven decentralization, combined with advances in portable concentrator technology and supportive digital ecosystems, creates distinct pathways for growth in home healthcare and ambulatory settings while preserving the role of centralized liquid oxygen in specific high-volume contexts. Regulatory and policy shifts, including trade-related measures, are reshaping manufacturing and sourcing priorities, elevating the importance of regional production capability and supplier diversification.

Commercial success will hinge on the ability to align product innovation with demonstrable clinical value and reliable service delivery. Firms that can combine efficient device platforms with robust aftersales networks and data-enabled service offerings will be better positioned to capture durable customer relationships. In sum, the oxygen therapy device sector is entering a phase where clinical needs, technology maturation, and policy dynamics are collectively driving strategic differentiation; organizations that respond proactively with integrated product and service strategies will realize the greatest advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of IoT-enabled remote monitoring features in oxygen therapy devices to support telehealth services
  • 5.2. Development of hybrid oxygen concentrators combining continuous flow and pulse dose delivery for patient flexibility
  • 5.3. Expansion of home oxygen therapy reimbursement policies driving increased adoption among chronic respiratory patients
  • 5.4. Advancements in compact and lightweight portable oxygen devices enabling extended battery life for outdoor activities
  • 5.5. Emergence of AI-powered oxygen delivery systems optimizing flow rates based on real-time patient health metrics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oxygen Therapy Devices Market, by Product Type

  • 8.1. Liquid Oxygen System
  • 8.2. Oxygen Concentrator
    • 8.2.1. Portable Oxygen Concentrator
    • 8.2.2. Stationary Oxygen Concentrator
  • 8.3. Oxygen Cylinder

9. Oxygen Therapy Devices Market, by Technology

  • 9.1. Cryogenic Distillation
  • 9.2. Membrane Separation
  • 9.3. Pressure Swing Adsorption

10. Oxygen Therapy Devices Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Home Healthcare
  • 10.3. Hospitals And Clinics

11. Oxygen Therapy Devices Market, by Application

  • 11.1. Asthma & Other Lung Diseases
  • 11.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 11.3. Obstructive Sleep Apnea (OSA)
  • 11.4. Pneumonia & Respiratory Distress Syndrome

12. Oxygen Therapy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Oxygen Therapy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Oxygen Therapy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Koninklijke Philips N.V.
    • 15.3.2. ResMed Inc.
    • 15.3.3. Chart Industries, Inc.
    • 15.3.4. Inogen, Inc.
    • 15.3.5. Drive DeVilbiss Healthcare, Inc.
    • 15.3.6. Invacare Corporation
    • 15.3.7. GE HealthCare Technologies Inc.
    • 15.3.8. Parker-Hannifin Corporation
    • 15.3.9. Nidek Medical Products, Inc.
    • 15.3.10. O2 Concepts, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. OXYGEN THERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. OXYGEN THERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OXYGEN THERAPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 222. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 223. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 247. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 258. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 259. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 270. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 271. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 283. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 293. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 295. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 303. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 304. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 305. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 312. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 313. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)

TABLE